Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical characteristics, treatment patterns, and outcomes in adult patients with germline BRCA1/2-mutated, HER2-negative advanced breast cancer: a retrospective medical record review in the United States.
Obeid E, Parikh RC, Esterberg E, Arondekar B, Hitchens A, Arruda LS, Niyazov A, Whitaker K. Obeid E, et al. Among authors: niyazov a. Front Oncol. 2024 May 16;14:1341665. doi: 10.3389/fonc.2024.1341665. eCollection 2024. Front Oncol. 2024. PMID: 38817906 Free PMC article.
Treatment Patterns and Clinical Outcomes Among Patients With Metastatic Prostate Cancer Harboring Homologous Recombination Repair Mutations.
Bobbili PJ, Ivanova J, Solit DB, Mettu NB, McCall SJ, Dhawan M, DerSarkissian M, Arondekar B, Chang J, Niyazov A, Lee J, Huq R, Green M, Turski M, Lam P, Muthukumar A, Guo T, Mohan M, Zhang A, Duh MS, Oh WK. Bobbili PJ, et al. Among authors: niyazov a. Clin Genitourin Cancer. 2024 Mar 23;22(3):102080. doi: 10.1016/j.clgc.2024.102080. Online ahead of print. Clin Genitourin Cancer. 2024. PMID: 38653037 Free article.
Neoadjuvant Talazoparib in Patients With Germline BRCA1/2 Mutation-Positive, Early-Stage Triple-Negative Breast Cancer: Results of a Phase II Study.
Litton JK, Beck JT, Jones JM, Andersen J, Blum JL, Mina LA, Brig R, Danso M, Yuan Y, Abbattista A, Noonan K, Niyazov A, Chakrabarti J, Czibere A, Symmans WF, Telli ML. Litton JK, et al. Among authors: niyazov a. Oncologist. 2023 Oct 3;28(10):845-855. doi: 10.1093/oncolo/oyad139. Oncologist. 2023. PMID: 37318349 Free PMC article. Clinical Trial.
Treatment Patterns, Safety, and Patient Reported Outcomes among Adult Women with Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer with or without, or with Unknown, BRCA1/2 Mutation(s): Results of a Real-World Study from the United States, United Kingdom, and four EU Countries.
Lux MP, Lewis K, Rider A, Niyazov A. Lux MP, et al. Among authors: niyazov a. Breast Care (Basel). 2022 Oct;17(5):460-469. doi: 10.1159/000523970. Epub 2022 Mar 11. Breast Care (Basel). 2022. PMID: 36684399 Free PMC article.
24 results